-
He also notes that Sprycel, the Bristol drug, is being tested in similar clinical trials.
FORBES: Pipelines
-
They include Abilify for schizophrenia and bipolar disorder, Reyataz for HIV, Orencia for rheumatoid arthritis and Sprycel for chronic myelogenous leukemia.
FORBES: Why Bristol And Sanofi Shouldn't Merge
-
Bristol-Myers Squibb ( BMY - news - people ) sells a drug called Sprycel that competes with Tasigna.
FORBES: Pipelines